Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease.

× No keyword cloud information.

53 in total

Review 1. Age and the cardiovascular system.

Authors: J Y Wei
Journal: N Engl J Med Date: 1992-12-10 Impact factor: 91.245

2. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.

Authors: K Swedberg; A Hjalmarson; F Waagstein; I Wallentin
Journal: Lancet Date: 1979-06-30 Impact factor: 79.321

3. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.

Authors:
Journal: Eur Heart J Date: 1985-03 Impact factor: 29.983

4. Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients.

Authors: M H Skinner; A Futterman; D Morrissette; L W Thompson; B B Hoffman; T F Blaschke
Journal: Ann Intern Med Date: 1992-04-15 Impact factor: 25.391

5. Impairment of memory function by antihypertensive medication.

Authors: S Solomon; E Hotchkiss; S M Saravay; C Bayer; P Ramsey; R S Blum
Journal: Arch Gen Psychiatry Date: 1983-10

6. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction?

Authors: M W Rich; M S Bosner; M K Chung; J Shen; J P McKenzie
Journal: Am J Med Date: 1992-01 Impact factor: 4.965

7. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.

Authors: U Goldbourt; S Behar; H Reicher-Reiss; M Zion; L Mandelzweig; E Kaplinsky
Journal: Arch Intern Med Date: 1993-02-08

8. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Authors:
Journal: Lancet Date: 1986-07-12 Impact factor: 79.321

Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease.